tenofovir disproxil fumarate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Tenofovir Disoproxil Fumarate.
Product ID | 0904-6821_da78a5d3-f5c6-47fe-b593-3252704c225d |
NDC | 0904-6821 |
Product Type | Human Prescription Drug |
Proprietary Name | tenofovir disproxil fumarate |
Generic Name | Tenofovir Disproxil Fumarate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-01-26 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA203232 |
Labeler Name | Major Pharmaceuticals |
Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-01-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA203232 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-01-26 |
Ingredient | Strength |
---|---|
TENOFOVIR DISOPROXIL FUMARATE | 300 mg/1 |
SPL SET ID: | da78a5d3-f5c6-47fe-b593-3252704c225d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0904-6821 | tenofovir disproxil fumarate | tenofovir disproxil fumarate |
33342-096 | tenofovir disproxil fumarate | tenofovir disproxil fumarate |